One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization

We evaluated 1-year outcomes of loading phase treatment followed by maintenance treatment using a treat-and-extend (TAE) regimen with intravitreal brolucizumab for neovascular age-related macular degeneration (nAMD) associated with type 1 macular neovascularization (MNV). We analyzed 68 eyes of 65 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hidetaka, Hoshino, Junki, Mukai, Ryo, Nakamura, Kosuke, Akiyama, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114020/
https://www.ncbi.nlm.nih.gov/pubmed/35581196
http://dx.doi.org/10.1038/s41598-022-10578-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114020/
https://www.ncbi.nlm.nih.gov/pubmed/35581196
http://dx.doi.org/10.1038/s41598-022-10578-1

Ejemplares similares